Mwandishi:
Mhariri:
Imeboershwa:
ULY CLINIC
ULY CLINIC
17 Februari 2026, 14:31:27
Anaphylaxis
Anaphylaxis is an acute, rapidly progressive, life-threatening systemic hypersensitivity reaction caused by sudden massive release of mediators from mast cells and basophils.
It commonly begins with:
Scalp itching
Diffuse erythema
Urticaria
Angioedema
This may rapidly progress to:
Bronchospasm
Laryngeal edema
Hypotension (shock)
Gastrointestinal hyperperistalsis
Cardiac arrhythmias
Common causes
Antibiotics (especially penicillins)
Other medications (NSAIDs, anesthetics)
Radiographic contrast media
Hymenoptera stings (bees, wasps)
Foods — especially crustaceans, nuts, eggs, milk
Pathophysiology
Usually IgE-mediated (Type I hypersensitivity):
Allergen exposure → IgE cross-linking → mast cell degranulation → release of:
Histamine
Leukotrienes
Prostaglandins
Cytokines
Effects:
Vasodilation → hypotension
Increased capillary permeability → edema
Bronchoconstriction → respiratory distress
Mucus secretion
Signs & Symptoms
Skin (most common)
Urticaria (hives)
Angioedema (lips, eyelids, tongue)
Flushing
Generalized itching
Respiratory
Shortness of breath
Wheezing
Stridor
Hoarseness
Laryngeal edema
Cardiovascular
Hypotension
Tachycardia
Dizziness
Syncope
Shock
Gastrointestinal
Abdominal cramps
Vomiting
Diarrhea
Neurologic
Anxiety
Confusion
Collapse
Diagnostic Criteria
Clinical diagnosis — do not delay treatment for tests
Anaphylaxis is highly likely if any ONE of the following occurs rapidly after exposure to allergen:
1. Skin involvement PLUS respiratory compromise or hypotension
OR
2. Two or more of:
Skin/mucosal symptoms
Respiratory compromise
Reduced blood pressure
Persistent gastrointestinal symptoms
OR
3. Hypotension after exposure to known allergen
Investigations
(After stabilization only)
Serum tryptase (within 1–3 hrs)
Full blood count
Renal and electrolytes
Arterial oxygen saturation
ECG if severe reaction
Allergy testing later (skin prick/IgE)
Treatment — MEDICAL EMERGENCY
Immediate First Aid (Non-Pharmacological)
Stop exposure to trigger
Call emergency help
Lay patient supine and elevate legs
Give high-flow oxygen
Secure airway
Establish IV access
Pharmacological Treatment
First-line (Life-saving)
Adrenaline (Epinephrine) IM — immediately
Adults: 0.5 mg (0.5 mL of 1:1000) IM lateral thigh
Children: 0.01 mg/kg IM (max 0.5 mg)
Repeat every 5–15 minutes if needed
Fluids
Rapid IV normal saline bolus (shock)
Adjunct Medications (AFTER adrenaline)**
Antihistamines:
Chlorpheniramine 4–16 mg POOR
Promethazine 25–50 mg POOR
Cetirizine 10 mg PO dailyOR
Loratadine 10 mg PO daily
⚠ Warn patient about drowsiness
Corticosteroids
Hydrocortisone IV (prevents biphasic reaction)
Bronchospasm
Salbutamol nebulization
Refractory Shock
IV adrenaline infusion (ICU care)
Observation
Monitor at least 6–24 hours (risk of biphasic reaction)
Prevention
Identify and avoid triggers (penicillin, foods, stings)
Medical alert bracelet
Prescribe adrenaline auto-injector if recurrent risk
Educate patient and family
Refer for allergy testing
Exclude drug reactions or infections in recurrent acute episodes
Complications
Airway obstruction
Cardiac arrest
Hypoxic brain injury
Death
Prognosis
Excellent with rapid adrenaline administration
Delayed treatment increases mortality
References
Tanzania Ministry of Health. Standard Treatment Guidelines & National Essential Medicines List (STG/NEMLIT). 7th ed. Dodoma: MoH; 2023.
World Allergy Organization. Anaphylaxis guidelines 2020 update. J Allergy Clin Immunol Pract. 2020.
Resuscitation Council UK. Emergency treatment of anaphylactic reactions. 2021.
Simons FER, Ardusso LRF, Bilò MB, et al. International consensus on anaphylaxis. Allergy. 2020.
World Health Organization. WHO Model Formulary 2023. Geneva: WHO; 2023.
Imeandikwa;
3 Novemba 2020, 12:24:20
